These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 19770176)

  • 1. Can erythropoietin improve developmental outcomes for preterm infants?
    McPherson RJ
    Pediatrics; 2009 Oct; 124(4):e805-6. PubMed ID: 19770176
    [No Abstract]   [Full Text] [Related]  

  • 2. Higher cumulative doses of erythropoietin and developmental outcomes in preterm infants.
    Brown MS; Eichorst D; Lala-Black B; Gonzalez R
    Pediatrics; 2009 Oct; 124(4):e681-7. PubMed ID: 19786428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An approach to using recombinant erythropoietin for neuroprotection in very preterm infants.
    Fauchère JC; Dame C; Vonthein R; Koller B; Arri S; Wolf M; Bucher HU
    Pediatrics; 2008 Aug; 122(2):375-82. PubMed ID: 18676556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase I/II trial of high-dose erythropoietin in extremely low birth weight infants: pharmacokinetics and safety.
    Juul SE; McPherson RJ; Bauer LA; Ledbetter KJ; Gleason CA; Mayock DE
    Pediatrics; 2008 Aug; 122(2):383-91. PubMed ID: 18676557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of early recombinant erythropoietin and enteral iron supplementation on blood transfusion in preterm infants.
    Türker G; Sarper N; Gökalp AS; Usluer H
    Am J Perinatol; 2005 Nov; 22(8):449-55. PubMed ID: 16283605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of repetitive antenatal steroid.
    Thorp JA
    Am J Obstet Gynecol; 2004 Dec; 191(6):2178-9; author reply 2179-80. PubMed ID: 15592314
    [No Abstract]   [Full Text] [Related]  

  • 7. Are high cumulative doses of erythropoietin neuroprotective in preterm infants? A two year follow-up report.
    Luciano R; Fracchiolla A; Ricci D; Cota F; D'Andrea V; Gallini F; Papacci P; Mercuri E; Romagnoli C
    Ital J Pediatr; 2015 Sep; 41():64. PubMed ID: 26376632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron supplementation in prematurity: how much is too much?
    Kling PJ
    J Pediatr; 2007 Jul; 151(1):3-4. PubMed ID: 17586179
    [No Abstract]   [Full Text] [Related]  

  • 9. Late preterm infants have worse 24-month neurodevelopmental outcomes than term infants.
    Woythaler MA; McCormick MC; Smith VC
    Pediatrics; 2011 Mar; 127(3):e622-9. PubMed ID: 21321024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of short- and long-term outcomes for very low birth weight infants: Edmonton NIDCAP trial.
    Peters KL; Rosychuk RJ; Hendson L; Coté JJ; McPherson C; Tyebkhan JM
    Pediatrics; 2009 Oct; 124(4):1009-20. PubMed ID: 19786440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Early use of recombinant human erythropoietin promotes neurobehavioral development in preterm infants].
    He JS; Huang ZL; Yang H; Weng KZ; Zhu SB
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Oct; 10(5):586-8. PubMed ID: 18947475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-year follow-up of a randomised trial with repeated antenatal betamethasone.
    Peltoniemi OM; Kari MA; Lano A; Yliherva A; Puosi R; Lehtonen L; Tammela O; Hallman M;
    Arch Dis Child Fetal Neonatal Ed; 2009 Nov; 94(6):F402-6. PubMed ID: 19531521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NIDCAP: new controversial evidence for its effectiveness.
    Ohlsson A
    Pediatrics; 2009 Oct; 124(4):1213-5. PubMed ID: 19786457
    [No Abstract]   [Full Text] [Related]  

  • 14. Erythropoietin therapy for anemia of prematurity.
    Merchant RH; Sonigara S; Sanghvi KP
    Indian Pediatr; 1996 Apr; 33(4):323-6. PubMed ID: 8772909
    [No Abstract]   [Full Text] [Related]  

  • 15. Neurodevelopmental Outcomes at Age 5 Years After Prophylactic Early High-Dose Recombinant Human Erythropoietin for Neuroprotection in Very Preterm Infants.
    Natalucci G; Latal B; Koller B; Rüegger C; Sick B; Held L; Fauchère JC;
    JAMA; 2020 Dec; 324(22):2324-2327. PubMed ID: 33289818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of low grade intraventricular hemorrhage on developmental outcome of preterm infants.
    Vavasseur C; Slevin M; Donoghue V; Murphy JF
    J Pediatr; 2007 Aug; 151(2):e6; author reply e6-7. PubMed ID: 17643747
    [No Abstract]   [Full Text] [Related]  

  • 17. Research on the sequelae of prematurity: early learning, early interventions and later outcomes.
    Scott DT; Spiker D
    Semin Perinatol; 1989 Dec; 13(6):495-505. PubMed ID: 2480645
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of changes in serum sodium levels on 2-year neurologic outcomes for very preterm neonates.
    Baraton L; Ancel PY; Flamant C; Orsonneau JL; Darmaun D; Rozé JC
    Pediatrics; 2009 Oct; 124(4):e655-61. PubMed ID: 19752079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of intervention strategies for at-risk preterm infants.
    Bos AF
    J Pediatr; 2010 Mar; 156(3):347-9. PubMed ID: 20176181
    [No Abstract]   [Full Text] [Related]  

  • 20. Developmental assessment of prematurely born children exposed to antenatal corticosteroids.
    Arad I; Bromiker R
    Isr Med Assoc J; 2003 Sep; 5(9):659-61. PubMed ID: 14509158
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.